ASO Author Reflections: Novel Evidence on Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer with Arterial Involvement

被引：0
|
作者：
Ikenaga, Naoki [1 ]
Miyasaka, Yoshihiro [2 ]
Ohtsuka, Takao [3 ]
Nakamura, Masafumi [1 ]
机构：
[1] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka, Japan
[2] Fukuoka Univ, Chikushi Hosp, Dept Surg, Chikushino, Japan
[3] Kagoshima Univ, Grad Sch Med Sci, Digest Surg Breast & Thyroid Surg, Kagoshima, Japan
来源：
ANNALS OF SURGICAL ONCOLOGY | 2023年 / 30卷 / 01期
关键词：
D O I：
10.1245/s10434-022-12584-z
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：203 / 204
页数：2
相关论文
共 50 条
  • [31] ASO Author Reflections: What is the Optimal Method for Predicting a Response to Neoadjuvant FOLFIRINOX Chemotherapy for Pancreatic Cancer?
    Won-Gun Yun
    Jin-Young Jang
    Annals of Surgical Oncology, 2024, 31 : 1364 - 1365
  • [32] ASO Author Reflections: Is Neoadjuvant Chemotherapy Associated with Acceptable Short-Term Outcomes for Pancreatic Cancer?
    Sivesh K. Kamarajah
    Fadi Dahdaleh
    Annals of Surgical Oncology, 2021, 28 : 1906 - 1907
  • [33] ASO Author Reflections: The Impact on Survival of Downstaging by Neoadjuvant Chemotherapy or Chemoradiotherapy in Pancreatic Adenocarcinoma
    Anne E. O’Shea
    Elizabeth L. Carpenter
    Daniel W. Nelson
    Timothy J. Vreeland
    Annals of Surgical Oncology, 2022, 29 : 6029 - 6030
  • [34] ASO Author Reflections: The Impact on Survival of Downstaging by Neoadjuvant Chemotherapy or Chemoradiotherapy in Pancreatic Adenocarcinoma
    O'Shea, Anne E.
    Carpenter, Elizabeth L.
    Nelson, Daniel W.
    Vreeland, Timothy J.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (09) : 6029 - 6030
  • [35] Effect of neoadjuvant chemoradiotherapy on prognosis in resectable and borderline resectable pancreatic cancer with venous involvement.
    Nagai, Minako
    Sho, Masayuki
    Akahori, Takahiro
    Nakagawa, Kenji
    Nakamura, Kota
    Takagi, Tadataka
    Tanaka, Toshihiro
    Nishiofuku, Hideyuki
    Kichikawa, Kimihiko
    Ikeda, Naoya
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [36] Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer
    Barreto, Savio George
    Shrikhande, Shailesh, V
    Sirohi, Bhawna
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2024, 15 (SUPPL 2) : 249 - 254
  • [37] ASO Author Reflections: Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer
    Andrianello, Stefano
    Marchegiani, Giovanni
    Salvia, Roberto
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : 810 - 811
  • [38] ASO Author Reflections: Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer
    Stefano Andrianello
    Giovanni Marchegiani
    Roberto Salvia
    Annals of Surgical Oncology, 2018, 25 : 810 - 811
  • [39] Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoadjuvant Chemotherapy
    Javed, Ammar A.
    Wright, Michael J.
    Siddique, Ayat
    Blair, Alex B.
    Ding, Ding
    Burkhart, Richard A.
    Makary, Martin
    Cameron, John L.
    Narang, Amol
    Herman, Joseph
    Zheng, Lei
    Laheru, Daniel
    Weiss, Matthew J.
    Wolfgang, Christopher
    He, Jin
    JOURNAL OF GASTROINTESTINAL SURGERY, 2019, 23 (01) : 112 - 121
  • [40] A Prospective Multicenter Phase II Trial of Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer with Arterial Involvement
    Ikenaga, Naoki
    Miyasaka, Yoshihiro
    Ohtsuka, Takao
    Nakata, Kohei
    Adachi, Tomohiko
    Eguchi, Susumu
    Nishihara, Kazuyoshi
    Inomata, Masafumi
    Kurahara, Hiroshi
    Hisaka, Toru
    Baba, Hideo
    Nagano, Hiroaki
    Ueki, Toshiharu
    Noshiro, Hirokazu
    Tokunaga, Shoji
    Ishigami, Kousei
    Nakamura, Masafumi
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (01) : 193 - 202
12345